Victor Cruz Molina

Victor Cruz Molina is an accomplished medical representative with extensive experience in the pharmaceutical industry. Currently serving as a medical representative at Carnot Laboratorios since November 2021, Victor previously held sales executive responsibilities at Merz from February 2016 to April 2021, where duties included managing hospital sales of Xeomeen, a botulinum toxin. Prior roles include serving as a medical representative at Grupo Rimsa from June 2009 to February 2016 and at The Janssen Pharmaceutical Companies of Johnson & Johnson from February 2004 to March 2007. Victor holds a degree in Communication Sciences with a focus on media studies from Universidad Autonoma de Guadalajara, completed in 2003.